Posted By admin Posted On

Covid-19: how France is preparing for a very large vaccination campaign


DECRYPTION – Pending validation before the vaccine is put on the market, the High Authority for Health has already started to build the framework for this future “unprecedented” vaccination campaign.

The American-German duo Pfizer-BioNTech announced in a statement Wednesday that it had reached the threshold of 170 patients required in its phase 3 clinical trial for its vaccine.
The American-German duo Pfizer-BioNTech announced in a statement Wednesday that it had reached the threshold of 170 patients required in its phase 3 clinical trial for its vaccine. Dado Ruvic / REUTERS

European countries are now preparing for the scenario of at least two vaccines against Covid-19 available from the first weeks of 2021. The most advanced is the candidate of the American-German duo Pfizer-BioNTech, which announced in a press release on Wednesday that it had reached the threshold of 170 patients required in its phase 3 clinical trial. According to its latest results, the vaccine, delivered in two doses at 21 day intervals, displays an efficiency rate of 95%, “Constant by sex, ethnicity and age”. Very encouragingly, protection reaches 94% among those over 65.

The main side effects observed are fatigue (3.8% of people vaccinated) and headaches (2%). Pfizer specifies that it will ask “In a few days” an emergency use authorization to the American Medicines Agency (FDA), and says it shares its results with other global health agencies, including the European Medicines Agency (EMA).

All

This article is for subscribers only. You have 72% left to discover.

Subscribe: 1 € the first month

Can be canceled at any time

.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *